HAI Clinical Trial
Official title:
Oxytocin Pathways and the Health Effects of Human-Animal Interaction
Verified date | September 2022 |
Source | University of Arizona |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study investigates the roles of oxytocin and vasopressin in human-animal interaction. Children will participate in three conditions involving friendly interactions with dogs, or play with toys at a university laboratory.
Status | Completed |
Enrollment | 30 |
Est. completion date | January 10, 2022 |
Est. primary completion date | January 10, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 8 Years to 10 Years |
Eligibility | Inclusion Criteria: - Participants in this study will include typically-developing children between 8-10 years. Enrollment will be limited to individuals who self-identify as white and not Hispanic or Latino for reasons related to the epigenetic analyses Exclusion Criteria: - known medical diseases or injuries involving the central nervous or endocrine systems, major physical abnormalities, seizures, and significant sensory, cognitive, or motor impairments |
Country | Name | City | State |
---|---|---|---|
United States | University of Arizona | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
University of Arizona | University of Virginia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concentration of salivary oxytocin (pg/mL) | Concentration of salivary oxytocin measured by immunoassay (pg/mL) | 15 minutes | |
Primary | Concentration of salivary vasopressin (pg/mL) | Concentration of salivary vasopressin measured by immunoassay (pg/mL) | 15 minutes | |
Primary | Concentration of urinary oxytocin (pg/mL) | Concentration of urinary oxytocin measured by immunoassay (pg/mL) | 50 minutes | |
Primary | Concentration of urinary vasopressin (pg/mL) | Concentration of urinary vasopressin measured by immunoassay (pg/mL) | 50 minutes | |
Primary | Concentration of salivary cortisol (ug/dL) | Concentration of salivary cortisol measured by immunoassay (ug/dL) | 50 minutes | |
Secondary | Principal component score reflecting positive affect | Principal component score from frequency and duration of positive affect indicators (smiling, laughing) coded by ethogram. Frequency and duration of smiling and laughing will be combined to report positive affect in an aggregate principal component score. | 30 minutes | |
Secondary | Principal component score reflecting affiliative social behavior | Principal component score from frequency and duration of affiliative behaviors (physical contact, eye gaze, dog-directed speech) coded by ethogram. Frequency and duration of physical contact, eye gaze, and dog-directed speech will be combined to report affiliative behavior in an aggregate principal component score. | 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05575050 -
Impact of Teeth Brushing in Ventilated COVID-19 Patients.
|
N/A | |
Terminated |
NCT03500874 -
Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM
|
Phase 3 |